Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
Acorda Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Acorda Therapeutics reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, five executives at Acorda Therapeutics received on average a compensation package of $1.5M, a 8% increase compared to previous year.
Average pay of disclosed executives at Acorda Therapeutics
Jane Wasman, General Counsel, received $2.4M in total, which increased by 67% compared to 2018.
For fiscal year 2019, the median employee pay was $179,362 at Acorda Therapeutics. Therefore, the ratio of Jane Wasman's pay to the median employee pay was 13 to one.
Ron Cohen, Chief Executive Officer, received a compensation package of $2M, which decreased by 16% compared to previous year. 39% of the compensation package, or $796K, was in salary.
Burkhard Blank, Chief Medical Officer, earned $1.2M in 2019, a 10% decrease compared to previous year.
Lauren Sabella, Chief Commercial Officer, received $922K in 2019, which decreases by 10% compared to 2018.
David Lawrence, Chief, Business Operations and Principal Accounting Officer, earned $913K in 2019, a 6% decrease compared to previous year.
Related executives
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
David Lawrence
Acorda Therapeutics
Former Chief, Business Operations and Principal Accounting Officer
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
Lauren Sabella
Acorda Therapeutics
Chief Operating Officer
Jane Wasman
Acorda Therapeutics
General Counsel
You may also like
Source: SEC filing on April 28, 2020.